L-Cysteine supplementation reduces high-glucose and ketone-induced adhesion of monocytes to endothelial cells by inhibiting ROS

Molecular and Cellular Biochemistry

Volumn 391, Issue 1-2, 2014, Pages 251-256

  Kanikarla Marie, Preeti ^a,b   Jain, Sushil K ^a,b  

^a Louisiana State University Health Sciences Center   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Acetoacetate; Adhesion; CVD; High glucose; L Cysteine; ROS

Indexed keywords

BIOLOGICAL MARKER; CYSTEINE; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; KETONE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CARDIOVASCULAR DISEASE; CELL ADHESION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MONOCYTE; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; BIOLOGICAL MODEL; CYTOLOGY; DIETARY SUPPLEMENT; DRUG EFFECTS; METABOLISM;

CELL ADHESION; CYSTEINE; DIETARY SUPPLEMENTS; ENDOTHELIAL CELLS; GLUCOSE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; KETONES; MODELS, BIOLOGICAL; MONOCYTES; REACTIVE OXYGEN SPECIES;

EID: 84900804161     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2009-3     Document Type: Article

References (55)

1. Devaraj S, Cheung AT, Jialal I, Griffen SC, Nguyen D, Glaser N, Aoki T (2007) Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes 56:2790-2796
2. Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The Framingham study. JAMA 241:2035-2038
3. Ghiadoni L, Huang Y, Magagna A, Buralli S, Taddei S, Salvetti A (2001) Effect of acute blood pressure reduction on endothelial function in the brachial artery of patients with essential hypertension. J Hypertens 19:547-551
4. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56:1113-1132
5. Foster JR, Morrison G, Fraser DD (2011) Diabetic ketoacidosisassociated stroke in children and youth. Stroke ResTreat 2011:219706
6. Candiloros H, Muller S, Zeghari N, Donner M, Drouin P, Ziegler O (1995) Decreased erythrocyte membrane fluidity in poorly controlled IDDM: influence of ketone bodies. Diabetes Care 18:549-551
7. Ebaid H, Salem A, Sayed A, Metwalli A (2011) Whey protein enhances normal inflammatory responses during cutaneous wound healing in diabetic rats. Lipids Health Dis 10:235
8. Hamad EM, Taha SH, Abou Dawood AG, Sitohy MZ, Abdel-Hamid M (2011) Protective effect of whey proteins against nonalcoholic fatty liver in rats. Lipids Health Dis 10:57
9. Xu R, Liu N, Xu X, Kong B (2011) Antioxidative effects of whey protein on peroxide-induced cytotoxicity. J Dairy Sci 94:3739-3746
10. Zavorsky GS, Kubow S, Grey V, Riverin V, Lands LC (2007) An open-label dose-response study of lymphocyte glutathione levels in healthy men and women receiving pressurized whey protein isolate supplements. Int J Food Sci Nutr 58:429-436
11. Micke P, Beeh KM, Buhl R (2002) Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients. Eur J Nutr 41:12-18
12. de Aguilar-Nascimento JE, Prado Silveira BR, Dock-Nascimento DB (2010) Early enteral nutrition with whey protein or casein in elderly patients with acute ischemic stroke: a double-blind randomized trial. Nutrition 27:440-444
13. Pal S, Ellis V (2009) The chronic effects of whey proteins on blood pressure, vascular function, and inflammatory markers in overweight individuals. Obesity (Silver Spring) 18:1354-1359
14. Ballard KD, Bruno RS, Seip RL, Quann EE, Volk BM, Freidenreich DJ, Kawiecki DM, Kupchak BR, Chung MY, Kraemer WJ, Volek JS (2009) Acute ingestion of a novel whey-derived peptide improves vascular endothelial responses in healthy individuals: a randomized, placebo controlled trial. Nutr J 8:34
15. Ballard KD, Kupchak BR, Volk BM, Mah E, Shkreta A, Liptak C, Ptolemy AS, Kellogg MS, Bruno RS, Seip RL, Maresh CM, Kraemer WJ, Volek JS (2012) Acute effects of ingestion of a novel whey-derived extract on vascular endothelial function in overweight, middle-aged men and women. Br J Nutr 109:882-893
16. Ballard KD, Mah E, Guo Y, Pei R, Volek JS, Bruno RS (2013) Low-fat milk ingestion prevents postprandial hyperglycemiamediated impairments in vascular endothelial function in obese individuals with metabolic syndrome. J Nutr 143: 1602-1610
17. Chitapanarux T, Tienboon P, Pojchamarnwiputh S, Leelarungrayub D (2009) Open-labeled pilot study of cysteine-rich whey protein isolate supplementation for nonalcoholic steato-hepatitis patients. J Gastroenterol Hepatol 24:1045-1050
18. Jain SK, McVie R (1999) Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients. Diabetes 48:1850-1855
19. Jain SK (1989) Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J Biol Chem 264:21340-21345
20. Rains JL, Jain SK (2010) Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 50:567-575
21. Tesfamariam B, Cohen RA (1992) Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol Heart Circ Physiol 263:H321-H326
22. Fatehi-Hassanabad Z, Chan CB, Furman BL (2010) Reactive oxygen species and endothelial function in diabetes. Eur J Pharmacol 636:8-17
23. Potenza MA, Gagliardi S, Nacci C, Carratu MR, Montagnani M (2009) Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem 16:94-112
24. Lum H, Roebuck KA (2001) Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 280:C719-C741
25. Wollesen F, Brattstrom L, Refsum H, Ueland PM, Berglund L, Berne C (1999) Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int 55:1028-1035
26. Anders MW, Dekant W (1994) Aminoacylases. Adv Pharmacol 27:431-448
27. Andrews NP, Prasad A, Quyyumi AA (2001) N-Acetylcysteine improves coronary and peripheral vascular function. J Am Coll Cardiol 37:117-123
28. Diniz YS, Rocha KK, Souza GA, Galhardi CM, Ebaid GM, Rodrigues HG, Novelli Filho JL, Cicogna AC, Novelli EL (2006) Effects of N-acetylcysteine on sucrose-rich diet-induced hyperglycaemia, dyslipidemia and oxidative stress in rats. Eur J Pharmacol 543:151-157
29. Jeremias A, Soodini G, Gelfand E, Xu Y, Stanton RC, Horton ES, Cohen DJ (2009) Effects of N-acetyl-L-cysteine on endothelial function and inflammation in patients with type 2 diabetes mellitus. Heart Int 4:25-29
30. Yamauchi A, Ueda N, Hanafusa S, Yamashita E, Kihara M, Naito S (2002) Tissue distribution of and species differences in deacetylation of N-acetyl-L-cysteine and immunohistochemical localization of acylase I in the primate kidney. J Pharm Pharmacol 54:205-212
31. Manna P, Jain SK (2011) Hydrogen sulfide and L-cysteine increase phosphatidylinositol 3,4,5-trisphosphate (PIP3) and glucose utilization by inhibiting phosphatase and tensin homolog (PTEN) protein and activating phosphoinositide 3-kinase (PI3K)/ serine/threonine protein kinase (AKT)/protein kinase Czeta/ lambda (PKCzeta/lambda) in 3T3l1 adipocytes. J Biol Chem 286:39848-39859
32. Manna P, Jain SK (2013) L-Cysteine and hydrogen sulfide increase PIP3 and AMPK/PPARgamma expression and decrease ROS and vascular inflammation markers in high glucose treated human U937 monocytes. J Cell Biochem 114:2334-2345
33. Jain SK, Velusamy T, Croad JL, Rains JL, Bull R (2009) L-Cysteinesupplementation lowers blood glucose, glycated hemoglobin, CRP, MCP-1, and oxidative stress and inhibits NF-kappaB activation in the livers of Zucker diabetic rats. Free Radic Biol Med 46:1633-1638
34. Iyer SS, Accardi CJ, Ziegler TR, Blanco RA, Ritzenthaler JD, Rojas M, Roman J, Jones DP (2009) Cysteine redox potential determines pro-inflammatory IL-1beta levels. PLoS ONE 4:e5017
35. Sekhar RV, Patel SG, Guthikonda AP, Reid M, Balasubramanyam A, Taffet GE, Jahoor F (2011) Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr 94:847-853
36. Fukao T, Lopaschuk GD, Mitchell GA (2004) Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot Essent Fatty Acids 70:243-251
37. Candiloros H, Muller S, Zeghari N, Donner M, Drouin P, Ziegler O (1995) Decreased erythrocyte membrane fluidity in poorly controlled IDDM. Influence of ketone bodies. Diabetes Care 18:549-551
38. Kim JA, Berliner JA, Natarajan RD, Nadler JL (1994) Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes 43:1103-1107
39. van den Brandhof WE, Haks K, Schouten EG, Verhoef P (2001) The relation between plasma cysteine, plasma homocysteine and coronary atherosclerosis. Atherosclerosis 157:403-409
40. Burlet E, Jain SK (2013) Manganese supplementation reduces high glucose-induced monocyte adhesion to endothelial cells and endothelial dysfunction in Zucker diabetic fatty rats. J Biol Chem 288:6409-6416
41. Rains JL, Jain SK (2011) Hyperketonemia increases monocyte adhesion to endothelial cells and is mediated by LFA-1 expression in monocytes and ICAM-1 expression in endothelial cells. Am J Physiol Endocrinol Metab 301:E298-E306
42. Jain SK, Kannan K, Lim G (1998) Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. Free Radic Biol Med 25:1083-1088
43. Garber AJ, Menzel PH, Boden G, Owen OE (1974) Hepatic ketogenesis and gluconeogenesis in humans. J Clin Investig 54:981-989
44. Owen OE, Felig P, Morgan AP, Wahren J, Cahill GF Jr (1969) Liver and kidney metabolism during prolonged starvation. J Clin Investig 48:574-583
45. Carl GF, Hoffman WH, Passmore GG, Truemper EJ, Lightsey AL, Cornwell PE, Jonah MH (2003) Diabetic ketoacidosis promotes a prothrombotic state. Endocr Res 29:73-82
46. Jain SK, McVie R, Jackson R, Levine SN, Lim G (1999) Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients. Diabetes Care 22:1171-1175
47. Ganini D, Christoff M, Ehrenshaft M, Kadiiska MB, Mason RP, Bechara EJ (2011) Myoglobin-H2 O2 catalyzes the oxidation of beta-ketoacids to alpha-dicarbonyls: mechanism and implications in ketosis. Free Radic Biol Med 51:733-743
48. Abdelmegeed MA, Kim SK, Woodcroft KJ, Novak RF (2004) Acetoacetate activation of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in primary cultured rat hepatocytes: role of oxidative stress. J Pharmacol Exp Ther 310:728-736
49. Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV Jr, de Cabo R, Ulrich S, Akassoglou K, Verdin E (2012) Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339:211-214
50. Hoffman WH, Cheng C, Passmore GG, Carroll JE, Hess D (2002) Acetoacetate increases expression of intercellular adhesion molecule-1 (ICAM-1) in human brain microvascular endothelial cells. Neurosci Lett 334:71-74
51. Fogelstrand L, Hulthe J, Hulten LM, Wiklund O, Fagerberg B (2004) Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance. Diabetologia 47:1948-1952
52. Mysliwiec J, Kretowski A, Kinalski M, Kinalska I (1999) CD11a expression and soluble ICAM-1 levels in peripheral blood in high-risk and overt type 1 diabetes subjects. Immunol Lett 70:69-72
53. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868-874
54. Galkina E, Ley K (2007) Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 27:2292-2301
55. Aune D, Norat T, Romundstad P, Vatten LJ (2013) Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am J Clin Nutr 98:1066-1083